Clinical Trial Update: Mesalazine for the Treatment of Diarrhoea-predominant Irritable Bowel Syndrome (IBS-D) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluated mesalazine for diarrhea-predominant irritable bowel syndrome and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Diarrhoea

Drugs mentioned

• Mesalazine (mesalazine)

Snippet

Sponsor: University of Nottingham | Conditions: Irritable Bowel Syndrome With Diarrhoea | Phase 4 | Status: COMPLETED